Aspirin use, lipoprotein(a), and calcific aortic valve disease: the Multi-ethnic Study of Atherosclerosis

By afschroeder • February 21, 2026

Razavi AC, Bhatia HS, Marrero N, Dzaye O, Post WS, Nasir K, Tsai M, Vaccarino V, Vasan RS, Thanassoulis G, Tsimikas S, Sperling LS, Budoff MJ, Blumenthal RS, Blaha MJ, Whelton SP. Aspirin use, lipoprotein(a), and calcific aortic valve disease: the Multi-ethnic Study of Atherosclerosis. Eur Heart J. 2026 Feb 21:ehag018. doi: 10.1093/eurheartj/ehag018. Epub ahead of print. PMID: 41721439.

Tags: Aortic stenosis, aortic valve calcium, Aortic valve disease, Aspirin, Cardiology/Epi, Computed tomography, Harbor UCLA, LDL cholesterol, lipoprotein(a), Publications

Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis

Umbleja T, Zafar MU, McCallum S, Gattu AK, Zanni MV, Bloomfield GS, Malvestutto CD, Fichtenbaum CJ, Currier JS, Sponseller CA, Diggs MR, Chu SM, Lu[...]

Trends and Disparities in Aortic Stenosis and Coronary Artery Disease-Related Mortality Among U.S. Adults Aged ≥65 Years, 1999-2024

Daniyal SM, Sarwar M, Fahim SL, Khatoon NM, Noor A, Batool F, Riaz M, Ajaz H, Gondal HT, Aftab Z, Gul I, Fonarow GC. Trends[...]

Comparison of Inpatient End-of-Life Care Intensity Between Heart Failure and Cancer

Halloran S, Meng Z, Harap R, Baldridge A, Wilcox J, Rao A, Adaboh A, Fonarow GC, Allen LA, Tibrewala A, Chuzi S. Comparison of Inpatient[...]